{"DataElement":{"publicId":"7736579","version":"1","preferredName":"Tumor Clinical T Stage","preferredDefinition":"Extent of the primary tumor determined prior to treatment based on evidence obtained from clinical assessment parameters (physical examination, imaging, endoscopy, etc.). The AJCC staging version to use is protocol specific.","longName":"RSORRES_TSTAGE","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"7736532","version":"1","preferredName":"Disease Response Domain Clinical T Category","preferredDefinition":"A domain for disease response evaluations._Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"6608777v1.0:2207100v1.0","context":"Theradex","contextVersion":"1","ObjectClass":{"publicId":"6608777","version":"1","preferredName":"Disease Response Domain","preferredDefinition":"A domain for disease response evaluations.","longName":"C107097","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Response Domain","conceptCode":"C107097","definition":"A domain for disease response evaluations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F6DD03A-0CB9-71AE-E053-F662850AB42C","latestVersionIndicator":"Yes","beginDate":"2019-01-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-14","modifiedBy":"ONEDATA","dateModified":"2019-01-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207100","version":"1","preferredName":"Clinical T Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"C25398:C25728","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-183F-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6EF621A-50E4-184F-E053-4EBD850A2F96","latestVersionIndicator":"Yes","beginDate":"2021-07-12","endDate":null,"createdBy":"TITARENI","dateCreated":"2021-07-12","modifiedBy":"ZHANGWE","dateModified":"2021-07-13","changeDescription":"07/12/2021 created for Theradex_TI","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7736576","version":"1","preferredName":"Clinical T Category Stage","preferredDefinition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion)._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"7736576v1.0","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Ta","valueDescription":"Ta Stage Finding","ValueMeaning":{"publicId":"3205588","version":"1","preferredName":"Ta Stage Finding","longName":"3205588","preferredDefinition":"A term that refers to a TNM finding of a primary, non-invasive, papillary cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pTa TNM Finding","conceptCode":"C96025","definition":"A term that refers to a TNM finding of a primary, non-invasive, papillary cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9EC6B910-A661-E8D4-E040-BB89AD43022D","latestVersionIndicator":"Yes","beginDate":"2011-03-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C6F1214D-ED3B-67B9-E053-4EBD850A0950","beginDate":"2021-07-12","endDate":null,"createdBy":"TITARENI","dateCreated":"2021-07-12","modifiedBy":"ONEDATA","dateModified":"2021-07-12","deletedIndicator":"No"},{"value":"T4b","valueDescription":"T4b Stage Finding","ValueMeaning":{"publicId":"3201439","version":"1","preferredName":"T4b Stage Finding","longName":"3201439","preferredDefinition":"A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T4b TNM finding depends on the specific type of cancer that it refers to; for example, for bladder cancer it refers to a primary tumor that invades the pelvic wall and abdominal wall; for gastric cancer it refers to a primary tumor that invades adjacent structures; for colorectal cancer it refers to a primary tumor with direct invasion or adherence to other organs or structures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T4b TNM Finding","conceptCode":"C48734","definition":"A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T4b TNM finding depends on the specific type of cancer that it refers to; for example, for bladder cancer it refers to a primary tumor that invades the pelvic wall and abdominal wall; for gastric cancer it refers to a primary tumor that invades adjacent structures; for colorectal cancer it refers to a primary tumor with direct invasion or adherence to other organs or structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3E57-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C6F1214D-ED46-67B9-E053-4EBD850A0950","beginDate":"2021-07-12","endDate":null,"createdBy":"TITARENI","dateCreated":"2021-07-12","modifiedBy":"ONEDATA","dateModified":"2021-07-12","deletedIndicator":"No"},{"value":"T4a","valueDescription":"T4a Stage Finding","ValueMeaning":{"publicId":"3371635","version":"1","preferredName":"T4a Stage Finding","longName":"3371635","preferredDefinition":"A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T4a TNM finding depends on the specific type of cancer that it refers to; for example, for bladder cancer it refers to a primary tumor that invades the prostatic stroma, uterus, and vagina; for gastric cancer it refers to a primary tumor that invades the serosa (visceral peritoneum); for colorectal cancer it refers to a primary tumor that penetrates to the surface of the visceral peritoneum.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T4a TNM Finding","conceptCode":"C48733","definition":"A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T4a TNM finding depends on the specific type of cancer that it refers to; for example, for bladder cancer it refers to a primary tumor that invades the prostatic stroma, uterus, and vagina; for gastric cancer it refers to a primary tumor that invades the serosa (visceral peritoneum); for colorectal cancer it refers to a primary tumor that penetrates to the surface of the visceral peritoneum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B86257A8-C9CF-3BD6-E040-BB89AD43018B","latestVersionIndicator":"Yes","beginDate":"2012-02-07","endDate":null,"createdBy":"PATELV","dateCreated":"2012-02-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C6F1214D-ED51-67B9-E053-4EBD850A0950","beginDate":"2021-07-12","endDate":null,"createdBy":"TITARENI","dateCreated":"2021-07-12","modifiedBy":"ONEDATA","dateModified":"2021-07-12","deletedIndicator":"No"},{"value":"pT3b","valueDescription":"PT3b Stage Finding","ValueMeaning":{"publicId":"5529022","version":"1","preferredName":"PT3b Stage Finding","longName":"5529022","preferredDefinition":"A pathologic primary tumor TNM stage finding.  The definition of pT3b stage finding depends on the particular type of cancer that it refers to; for example, for cervical cancer, pT3b stage finding is defined as follows:cancer extends to pelvic wall and/or causes hydronephrosis or nonfunctioning kidney; for kidney cancer, pT3b stage finding is defined as follows: cancer with tumor grossly extending into the vena cava below the diaphragm. (from AJCC 7th Ed.)","context":"TEST","contextVersion":"1","Concepts":[{"longName":"pT3b TNM Finding","conceptCode":"C48770","definition":"A pathologic primary tumor TNM finding. The definition of pT3b finding depends on the particular type of cancer that it refers to; for example, for cervical cancer, pT3b finding is defined as follows:cancer extends to pelvic wall and/or causes hydronephrosis or nonfunctioning kidney; for kidney cancer, pT3b finding is defined as follows: cancer with tumor grossly extending into the vena cava below the diaphragm. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F500EAA-339A-1B42-E053-F662850AB23F","latestVersionIndicator":"Yes","beginDate":"2016-10-20","endDate":null,"createdBy":"UMLLOADER_EDRN","dateCreated":"2016-10-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C6F1214D-ED66-67B9-E053-4EBD850A0950","beginDate":"2021-07-12","endDate":null,"createdBy":"TITARENI","dateCreated":"2021-07-12","modifiedBy":"ONEDATA","dateModified":"2021-07-12","deletedIndicator":"No"},{"value":"pT3a","valueDescription":"PT3a Stage Finding","ValueMeaning":{"publicId":"5529021","version":"1","preferredName":"PT3a Stage Finding","longName":"5529021","preferredDefinition":"A pathologic primary tumor TNM stage finding.  The definition of pT3a stage finding depends on the particular type of cancer that it refers to; for example, for cervical cancer, pT3a stage finding is defined as follows: cancer involves lower third of vagina, without extension to pelvic wall; for kidney cancer, pT3a stage finding is defined as follows: cancer with tumor grossly extending into the renal vein or its segmental (muscle containing) branches or tumor invading perirenal and/or renal sinus fat but not beyond Gerota's fascia. (from AJCC 7th Ed.)","context":"TEST","contextVersion":"1","Concepts":[{"longName":"pT3a TNM Finding","conceptCode":"C48769","definition":"A pathologic primary tumor TNM finding. The definition of pT3a finding depends on the particular type of cancer that it refers to; for example, for cervical cancer, pT3a finding is defined as follows: cancer involves lower third of vagina, without extension to pelvic wall; for kidney cancer, pT3a finding is defined as follows: cancer with tumor grossly extending into the renal vein or its segmental (muscle containing) branches or tumor invading perirenal and/or renal sinus fat but not beyond Gerota's fascia. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F500EAA-3378-1B42-E053-F662850AB23F","latestVersionIndicator":"Yes","beginDate":"2016-10-20","endDate":null,"createdBy":"UMLLOADER_EDRN","dateCreated":"2016-10-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C6F1214D-ED7B-67B9-E053-4EBD850A0950","beginDate":"2021-07-12","endDate":null,"createdBy":"TITARENI","dateCreated":"2021-07-12","modifiedBy":"ONEDATA","dateModified":"2021-07-12","deletedIndicator":"No"},{"value":"T3","valueDescription":"T3 Stage Finding","ValueMeaning":{"publicId":"3201433","version":"1","preferredName":"T3 Stage Finding","longName":"3201433","preferredDefinition":"A clinical and/or pathologic primary tumor TNM finding usually indicating that the cancer is locally invasive, without infiltration of adjacent structures.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T3 TNM Finding","conceptCode":"C48728","definition":"A clinical and/or pathologic primary tumor TNM finding usually indicating that the cancer is locally invasive, without infiltration of adjacent structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3D7B-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"GDEEN","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C6F1214D-ED86-67B9-E053-4EBD850A0950","beginDate":"2021-07-12","endDate":null,"createdBy":"TITARENI","dateCreated":"2021-07-12","modifiedBy":"ONEDATA","dateModified":"2021-07-12","deletedIndicator":"No"},{"value":"pT2b","valueDescription":"PT2b Stage Finding","ValueMeaning":{"publicId":"5529005","version":"1","preferredName":"PT2b Stage Finding","longName":"5529005","preferredDefinition":"A pathologic primary tumor TNM stage finding.  The definition of pT2b stage finding depends on the particular type of cancer that it refers to; for example, for prostate cancer, pT2b stage finding is defined as follows: cancer involving more than one-half of one lobe, but not both lobes of the prostate gland; for lung cancer, pT2b stage finding is defined as follows: cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension. (from AJCC 7th Ed.)","context":"TEST","contextVersion":"1","Concepts":[{"longName":"pT2b TNM Finding","conceptCode":"C48766","definition":"A pathologic primary tumor TNM finding. The definition of pT2b finding depends on the particular type of cancer that it refers to; for example, for prostate cancer, pT2b finding is defined as follows: cancer involving more than one-half of one lobe, but not both lobes of the prostate gland; for lung cancer, pT2b finding is defined as follows: cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F500DB1-14A7-1A58-E053-F662850AB419","latestVersionIndicator":"Yes","beginDate":"2016-10-20","endDate":null,"createdBy":"UMLLOADER_EDRN","dateCreated":"2016-10-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C6F1214D-ED9B-67B9-E053-4EBD850A0950","beginDate":"2021-07-12","endDate":null,"createdBy":"TITARENI","dateCreated":"2021-07-12","modifiedBy":"ONEDATA","dateModified":"2021-07-12","deletedIndicator":"No"},{"value":"pT2a","valueDescription":"PT2a Stage Finding","ValueMeaning":{"publicId":"5529004","version":"1","preferredName":"PT2a Stage Finding","longName":"5529004","preferredDefinition":"A pathologic primary tumor TNM stage finding.  The definition of pT2a stage finding depends on the particular type of cancer that it refers to; for example, for prostate cancer, pT2a stage finding is defined as follows: cancer limited to one-half or less of one lobe of the prostate gland; for lung cancer, pT2a stage finding is defined as follows: cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension. (from AJCC 7th Ed.)","context":"TEST","contextVersion":"1","Concepts":[{"longName":"pT2a TNM Finding","conceptCode":"C48765","definition":"A pathologic primary tumor TNM finding. The definition of pT2a finding depends on the particular type of cancer that it refers to; for example, for prostate cancer, pT2a  finding is defined as follows: cancer limited to one-half or less of one lobe of the prostate gland; for lung cancer, pT2a finding is defined as follows: cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F500DB1-1485-1A58-E053-F662850AB419","latestVersionIndicator":"Yes","beginDate":"2016-10-20","endDate":null,"createdBy":"UMLLOADER_EDRN","dateCreated":"2016-10-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C6F1214D-EDB0-67B9-E053-4EBD850A0950","beginDate":"2021-07-12","endDate":null,"createdBy":"TITARENI","dateCreated":"2021-07-12","modifiedBy":"ONEDATA","dateModified":"2021-07-12","deletedIndicator":"No"},{"value":"T4","valueDescription":"T4 Stage Finding","ValueMeaning":{"publicId":"3201437","version":"1","preferredName":"T4 Stage Finding","longName":"3201437","preferredDefinition":"A clinical and/or pathologic primary tumor TNM finding indicating direct invasion of adjacent structures by cancer.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T4 TNM Finding","conceptCode":"C48732","definition":"A clinical and/or pathologic primary tumor TNM finding indicating direct invasion of adjacent structures by cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3E0D-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"GDEEN","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C6F1214D-EDBB-67B9-E053-4EBD850A0950","beginDate":"2021-07-12","endDate":null,"createdBy":"TITARENI","dateCreated":"2021-07-12","modifiedBy":"ONEDATA","dateModified":"2021-07-12","deletedIndicator":"No"},{"value":"T2","valueDescription":"T2 Stage Finding","ValueMeaning":{"publicId":"3201429","version":"1","preferredName":"T2 Stage Finding","longName":"3201429","preferredDefinition":"A general term that refers to a TNM finding of primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to primary tumor that is more than 2.0 cm, but not more than 5.0 cm in greatest dimension; for cutaneous melanoma it refers to primary tumor that is 1.01 to 2 mm in thickness, with or without ulceration; for colorectal cancer it refers to primary tumor with invasion into the muscularis propria; and for bladder cancer it refers to primary tumor with invasion into the muscle layer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T2 TNM Finding","conceptCode":"C48724","definition":"A general term that refers to a TNM finding of primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to primary tumor that is more than 2.0 cm, but not more than 5.0 cm in greatest dimension; for cutaneous melanoma it refers to primary tumor that is 1.01 to 2 mm in thickness, with or without ulceration; for colorectal cancer it refers to primary tumor with invasion into the muscularis propria; and for bladder cancer it refers to primary tumor with invasion into the muscle layer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3CE9-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C6F1214D-EDC6-67B9-E053-4EBD850A0950","beginDate":"2021-07-12","endDate":null,"createdBy":"TITARENI","dateCreated":"2021-07-12","modifiedBy":"ONEDATA","dateModified":"2021-07-12","deletedIndicator":"No"},{"value":"T1","valueDescription":"T1 Stage Finding","ValueMeaning":{"publicId":"3687408","version":"1","preferredName":"T1 Stage Finding","longName":"3687408","preferredDefinition":"A clinical and/or pathologic primary tumor TNM finding indicating that the cancer is limited to the site of growth.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T1 TNM Finding","conceptCode":"C48720","definition":"A clinical and/or pathologic primary tumor TNM finding indicating that the cancer is limited to the site of growth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5CA35AA-9F9B-FFA5-E040-BB89AD435F4C","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"PATELV","dateCreated":"2013-02-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C6F1214D-EDD1-67B9-E053-4EBD850A0950","beginDate":"2021-07-12","endDate":null,"createdBy":"TITARENI","dateCreated":"2021-07-12","modifiedBy":"ONEDATA","dateModified":"2021-07-12","deletedIndicator":"No"},{"value":"Tis","valueDescription":"Tis Stage Finding","ValueMeaning":{"publicId":"3201442","version":"1","preferredName":"Breast Cancer pTis TNM Finding v6 and v7","longName":"3201442v1.00","preferredDefinition":"Breast cancer with a finding of carcinoma in situ. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pTis TNM Finding v6 and v7","conceptCode":"C48974","definition":"Breast cancer with a finding of carcinoma in situ. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3EC4-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"MMADDINENI","dateModified":"2023-06-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C6F1214D-EDDC-67B9-E053-4EBD850A0950","beginDate":"2021-07-12","endDate":null,"createdBy":"TITARENI","dateCreated":"2021-07-12","modifiedBy":"ONEDATA","dateModified":"2021-07-12","deletedIndicator":"No"},{"value":"T0","valueDescription":"T0 Stage Finding","ValueMeaning":{"publicId":"3201423","version":"1","preferredName":"T0 Stage Finding","longName":"3201423","preferredDefinition":"A primary tumor TNM finding indicating that there is no evidence of primary tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T0 TNM Finding","conceptCode":"C48719","definition":"A primary tumor TNM finding indicating that there is no evidence of primary tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3C0F-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"ONEDATA","dateModified":"2011-03-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C6F1214D-EDE7-67B9-E053-4EBD850A0950","beginDate":"2021-07-12","endDate":null,"createdBy":"TITARENI","dateCreated":"2021-07-12","modifiedBy":"ONEDATA","dateModified":"2021-07-12","deletedIndicator":"No"},{"value":"Tx","valueDescription":"TX Stage Finding","ValueMeaning":{"publicId":"3201443","version":"1","preferredName":"TX Stage Finding","longName":"3201443","preferredDefinition":"A primary tumor TNM finding indicating that the status of the primary tumor cannot be assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TX TNM Finding","conceptCode":"C48737","definition":"A primary tumor TNM finding indicating that the status of the primary tumor cannot be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3EE7-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C6F1214D-EDFC-67B9-E053-4EBD850A0950","beginDate":"2021-07-12","endDate":null,"createdBy":"TITARENI","dateCreated":"2021-07-12","modifiedBy":"ONEDATA","dateModified":"2021-07-12","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5544740","version":"1","preferredName":"Clinical T Stage Stage","preferredDefinition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.:One criteria of the TNM staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).:The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C25398:C25728:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FD8CA1B-5181-734E-E053-F662850AB694","latestVersionIndicator":"Yes","beginDate":"2016-10-27","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-10-27","modifiedBy":"ONEDATA","dateModified":"2016-10-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6F1214D-ED24-67B9-E053-4EBD850A0950","latestVersionIndicator":"Yes","beginDate":"2021-07-12","endDate":null,"createdBy":"TITARENI","dateCreated":"2021-07-12","modifiedBy":"ZHANGWE","dateModified":"2021-07-13","changeDescription":"07/12/2021 created for Theradex_TI","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"RS_RSORRES_TSTAGE","type":"OID, CCTG","context":"CCTG"}],"ReferenceDocuments":[{"name":"T stage","type":"Preferred Question Text","description":"T stage","url":null,"context":"Theradex"},{"name":"CCTG_01","type":"Alternate Question Text","description":"cT-stage (based on pelvic MRI):","url":null,"context":"CCTG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6F12D6A-EB99-7CAB-E053-4EBD850A87AB","latestVersionIndicator":"Yes","beginDate":"2021-07-12","endDate":null,"createdBy":"TITARENI","dateCreated":"2021-07-12","modifiedBy":"CLOHNES","dateModified":"2023-09-26","changeDescription":"07/12/2021 created for Theradex_TI","administrativeNotes":"9/26/23 Added alt OID, CCTG and AQT for CCTG ticket number CADSR0002884 cjl.","unresolvedIssues":null,"deletedIndicator":"No"}}